BSE Live
Nov 14, 10:07Prev. Close
1958.75
Open Price
1968.60
Bid Price (Qty.)
1952.00 (10)
Offer Price (Qty.)
1954.50 (5)
NSE Live
Nov 14, 10:07Prev. Close
1958.90
Open Price
1967.00
Bid Price (Qty.)
1952.50 (1)
Offer Price (Qty.)
1954.00 (5)
| Balance Sheet of Poly Medicure (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 22.06 | 22.03 | 11.01 | 11.01 | 11.01 | |
| Total Share Capital | 22.06 | 22.03 | 11.01 | 11.01 | 11.01 | |
| Reserves and Surplus | 174.12 | 124.42 | 101.45 | 82.49 | 67.05 | |
| Total Reserves and Surplus | 174.12 | 124.42 | 101.45 | 82.49 | 67.05 | |
| Total Shareholders Funds | 196.18 | 146.46 | 112.46 | 93.50 | 78.06 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.06 | 0.11 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 40.25 | 38.65 | 24.17 | 18.33 | 12.44 | |
| Deferred Tax Liabilities [Net] | 10.28 | 7.97 | 6.29 | 5.37 | 3.17 | |
| Other Long Term Liabilities | 2.81 | 2.41 | 2.56 | 2.38 | 1.34 | |
| Long Term Provisions | 2.04 | 1.65 | 1.43 | 1.26 | 1.16 | |
| Total Non-Current Liabilities | 55.38 | 50.68 | 34.44 | 27.34 | 18.10 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 21.05 | 10.10 | 13.45 | 15.85 | 16.34 | |
| Trade Payables | 39.33 | 29.71 | 23.43 | 19.91 | 16.10 | |
| Other Current Liabilities | 38.50 | 38.50 | 25.11 | 20.64 | 20.23 | |
| Short Term Provisions | 13.58 | 10.51 | 5.60 | 4.43 | 4.40 | |
| Total Current Liabilities | 112.47 | 88.81 | 67.59 | 60.84 | 57.07 | |
| Total Capital And Liabilities | 364.02 | 285.95 | 214.49 | 181.75 | 153.34 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 160.66 | 119.76 | 89.24 | 83.43 | 67.26 | |
| Intangible Assets | 4.80 | 3.34 | 2.60 | 1.40 | 2.37 | |
| Capital Work-In-Progress | 4.15 | 13.35 | 3.46 | 1.27 | 5.51 | |
| Fixed Assets | 175.27 | 142.76 | 99.84 | 90.04 | 77.42 | |
| Non-Current Investments | 3.95 | 3.43 | 4.24 | 2.40 | 2.03 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 21.93 | 17.83 | 15.04 | 7.23 | 8.03 | |
| Other Non-Current Assets | 3.24 | 1.67 | 0.99 | 0.91 | 0.72 | |
| Total Non-Current Assets | 204.40 | 165.69 | 120.11 | 100.89 | 88.49 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 57.62 | 42.01 | 35.36 | 30.10 | 25.27 | |
| Trade Receivables | 62.81 | 45.75 | 43.38 | 33.46 | 26.75 | |
| Cash And Cash Equivalents | 19.98 | 13.83 | 0.80 | 0.68 | 0.61 | |
| Short Term Loans And Advances | 11.62 | 10.44 | 8.79 | 9.81 | 8.16 | |
| OtherCurrentAssets | 7.58 | 8.24 | 6.05 | 6.81 | 4.07 | |
| Total Current Assets | 159.62 | 120.26 | 94.38 | 80.86 | 64.85 | |
| Total Assets | 364.02 | 285.95 | 214.49 | 181.75 | 153.34 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 54.19 | 42.47 | 53.85 | 28.53 | 18.76 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 16.52 | 16.52 | 5.51 | 5.51 | 5.51 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 3.95 | 3.43 | 4.24 | 2.40 | 2.03 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
12.11.2025
Poly Medicure Standalone September 2025 Net Sales at Rs 416.54 crore, up 3.5% Y-o-Y
24.09.2025
04.09.2025
Poly Medicure shares gain on acquisition of Netherlands based company
04.09.2025
12.11.2025
Poly Medicure Standalone September 2025 Net Sales at Rs 416.54 crore, up 3.5% Y-o-Y
22.08.2025
Poly Medicure Standalone June 2025 Net Sales at Rs 384.05 crore, up 4.52% Y-o-Y
07.05.2025
Poly Medicure Standalone March 2025 Net Sales at Rs 420.97 crore, up 16.64% Y-o-Y
07.05.2025
Poly Medicure Consolidated March 2025 Net Sales at Rs 440.83 crore, up 16.6% Y-o-Y